Literature DB >> 10699988

Molecular interactions in the Vogelstein model of colorectal carcinoma.

J W Arends1.   

Abstract

For about a decade, the model proposed by Fearon and Vogelstein has been the paradigm of the genetic alterations involved in the development of colorectal carcinoma. During this time, much information has become available on the function of the key genes in this model, as well as on their interactions. This review examines the impact of this new knowledge on the Vogelstein model. It is concluded that the model as such still stands and with a few modifications could even be strengthened in that, contrary to the original proposal, the order of genetic events seems to be essential. Crucial molecular events include derangement of the Wnt- and defects in the transforming growth factor beta (TGFbeta)-signalling pathways, which exert a synergistic effect on the cell cycle. Finally, with loss of p53 function, several checks and balances are disrupted, which paves the way to gross chromosomal aberrations and aneuploidy. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699988     DOI: 10.1002/(SICI)1096-9896(200003)190:4<412::AID-PATH533>3.0.CO;2-P

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  29 in total

1.  Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas.

Authors:  Marian Grade; B Michael Ghadimi; Sudhir Varma; Richard Simon; Danny Wangsa; Linda Barenboim-Stapleton; Torsten Liersch; Heinz Becker; Thomas Ried; Michael J Difilippantonio
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

2.  Common denominator genes that distinguish colorectal carcinoma from normal mucosa.

Authors:  Roland S Croner; Thomas Foertsch; Wolfgang M Brueckl; Klaus Guenther; Renate Siebenhaar; Christian Stremmel; Klaus E Matzel; Thomas Papadopoulos; Thomas Kirchner; Jürgen Behrens; Ludger Klein-Hitpass; Michael Stuerzl; Werner Hohenberger; Bertram Reingruber
Journal:  Int J Colorectal Dis       Date:  2004-12-22       Impact factor: 2.571

3.  Inverse Correlation Between an Organ's Cancer Rate and Its Evolutionary Antiquity.

Authors:  Jamie A Davies
Journal:  Organogenesis       Date:  2004-10       Impact factor: 2.500

4.  Assessment of SMAD4, p53, and Ki-67 alterations as a predictor of liver metastasis in human colorectal cancer.

Authors:  Masayo Kawakami; Tatsuro Yamaguchi; Keiichi Takahashi; Hiroshi Matsumoto; Michiya Yasutome; Shinichiro Horiguchi; Yukiko Hayashi; Nobuaki Funata; Takeo Mori
Journal:  Surg Today       Date:  2010-02-24       Impact factor: 2.549

5.  Differential colorectal carcinogenesis: Molecular basis and clinical relevance.

Authors:  Alberto Morán; Paloma Ortega; Carmen de Juan; Tamara Fernández-Marcelo; Cristina Frías; Andrés Sánchez-Pernaute; Antonio José Torres; Eduardo Díaz-Rubio; Pilar Iniesta; Manuel Benito
Journal:  World J Gastrointest Oncol       Date:  2010-03-15

Review 6.  Genetic unraveling of colorectal cancer.

Authors:  Sabha Rasool; Vamiq Rasool; Tahira Naqvi; Bashir A Ganai; Bhahwal Ali Shah
Journal:  Tumour Biol       Date:  2014-02-27

7.  Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.

Authors:  Jinhua Zhang; Gottumakkala S Raju; David W Chang; Shu-Hong Lin; Zhinan Chen; Xifeng Wu
Journal:  Cancer       Date:  2017-11-07       Impact factor: 6.860

8.  MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease.

Authors:  Alexandru V Olaru; Sumitaka Yamanaka; Christine Vazquez; Yuriko Mori; Yulan Cheng; John M Abraham; Theodore M Bayless; Noam Harpaz; Florin M Selaru; Stephen J Meltzer
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

9.  Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system.

Authors:  D Qualtrough; T Hinoi; E Fearon; C Paraskeva
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

10.  Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer.

Authors:  Vid Mlakar; Gasper Berginc; Metka Volavsek; Zdravko Stor; Miran Rems; Damjan Glavac
Journal:  BMC Cancer       Date:  2009-08-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.